Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil after rituximab in childhood-onset complicated FRNS/SDNS (JSKDC07)
jRCTs051180081Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Idiopathic nephrotic syndrome (INS) comparing Rituximab + mycophenolate mofetil with Rituximab + placebo (2 arms). Primary endpoint: Time to treatment failure. Started Apr 2015; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Idiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on jRCTs051180081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180081.